BURLINGTON, N.C.--(BUSINESS WIRE)--Laboratory Corporation of America® Holdings (LabCorp®) (NYSE:LH) today announced that it has entered into an exclusive license agreement with Duke University Medical Center (Duke) to commercialize Duke’s new blood-based assay for early detection of lung cancer. Financial terms were not disclosed.
